Figure 9.Chemotherapy drug sensitivity. (A–F) IC50 of several chemotherapy drugs in BC. (A) Alisertib; (B) Buparlisib; (C) Dasatinib; (D) Cisplatin; (E) Sorafenib; (F) EPZ5676.
Figure 9 — Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer | Aging
